|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
77,921,000 |
Market
Cap: |
N/A |
Last
Volume: |
4,773,204 |
Avg
Vol: |
2,175,956 |
52
Week Range: |
$81.49 - $81.49 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
S&P 400 MIDCAP |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-29 |
2023-11-28 |
2023-05-30 |
2022-05-30 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Witzel Horst |
Director |
|
2006-02-21 |
4 |
OE |
$44.09 |
$3,257,200 |
D/D |
60,000 |
60,000 |
|
- |
|
Osborn John E |
Sr. VP, General Counsel & Sec. |
|
2006-02-21 |
4 |
S |
$73.77 |
$355,883 |
D/D |
(4,818) |
36,000 |
|
- |
|
Osborn John E |
Sr. VP, General Counsel & Sec. |
|
2006-02-21 |
4 |
S |
$73.97 |
$2,736,602 |
D/D |
(36,807) |
40,818 |
|
- |
|
Osborn John E |
Sr. VP, General Counsel & Sec. |
|
2006-02-21 |
4 |
OE |
$51.17 |
$2,129,951 |
D/D |
41,625 |
77,625 |
|
- |
|
Buchi J Kevin |
Sr. Vice President and CFO |
|
2006-02-21 |
4 |
GD |
$0.00 |
$0 |
D/D |
140 |
83,708 |
|
- |
|
Egan William P |
Director |
|
2006-02-21 |
4 |
S |
$73.95 |
$739,797 |
D/D |
(10,000) |
0 |
|
- |
|
Buchi J Kevin |
Chief Operating Officer |
|
2006-02-17 |
4 |
S |
$74.40 |
$2,134,090 |
D/D |
(28,684) |
56,555 |
|
- |
|
Savini Carl A |
Sr VP & Chief Admin Officer |
|
2006-02-17 |
4 |
S |
$73.45 |
$3,649,936 |
D/D |
(49,185) |
36,000 |
|
- |
|
Savini Carl A |
Sr VP & Chief Admin Officer |
|
2006-02-17 |
4 |
OE |
$7.88 |
$1,733,984 |
D/D |
39,125 |
85,185 |
|
- |
|
Osborn John E |
Sr. VP, General Counsel & Sec. |
|
2006-02-17 |
4 |
S |
$73.50 |
$863,227 |
D/D |
(11,721) |
36,000 |
|
- |
|
Osborn John E |
Sr. VP, General Counsel & Sec. |
|
2006-02-17 |
4 |
S |
$73.80 |
$3,011,183 |
D/D |
(40,597) |
47,721 |
|
- |
|
Osborn John E |
Sr. VP, General Counsel & Sec. |
|
2006-02-17 |
4 |
OE |
$48.06 |
$2,376,550 |
D/D |
47,500 |
88,318 |
|
- |
|
Vaught Jeffry L |
Sr. Vice Pres., and Pres., R&D |
|
2006-02-17 |
4 |
S |
$74.32 |
$2,822,212 |
D/D |
(37,900) |
45,502 |
|
- |
|
Vaught Jeffry L |
Sr. Vice Pres., and Pres., R&D |
|
2006-02-17 |
4 |
OE |
$7.88 |
$392,575 |
D/D |
37,900 |
83,402 |
|
- |
|
Roche Robert P Jr |
Exec VP, Worldwide Pharm Ops. |
|
2006-02-17 |
4 |
S |
$74.09 |
$2,263,450 |
D/D |
(30,550) |
41,980 |
|
- |
|
Roche Robert P Jr |
Exec VP, Worldwide Pharm Ops. |
|
2006-02-17 |
4 |
OE |
$7.88 |
$492,600 |
D/D |
23,700 |
72,530 |
|
- |
|
Greenacre Martyn D |
Director |
|
2006-02-17 |
4 |
S |
$74.45 |
$1,116,686 |
D/D |
(15,000) |
0 |
|
- |
|
Greenacre Martyn D |
Director |
|
2006-02-17 |
4 |
OE |
$12.88 |
$369,375 |
D/D |
15,000 |
15,000 |
|
- |
|
Buchi J Kevin |
Sr. Vice President and CFO |
|
2006-02-17 |
4 |
S |
$74.40 |
$2,163,127 |
D/D |
(29,073) |
83,848 |
|
- |
|
Buchi J Kevin |
Sr. Vice President and CFO |
|
2006-02-17 |
4 |
OE |
$7.88 |
$561,892 |
D/D |
29,073 |
112,921 |
|
- |
|
Grebow Peter E |
Exec VP,Worldwide Tech Ops. |
|
2006-02-17 |
4 |
S |
$73.25 |
$733,173 |
D/D |
(10,000) |
63,765 |
|
- |
|
Grebow Peter E |
Exec VP,Worldwide Tech Ops. |
|
2006-02-17 |
4 |
OE |
$17.75 |
$106,500 |
D/D |
6,000 |
73,765 |
|
- |
|
Blake Paul |
Exec VP, Clin Res & Reg Aff |
|
2006-02-17 |
4 |
S |
$74.50 |
$517,016 |
D/D |
(6,938) |
40,000 |
|
- |
|
Egan William P |
Director |
|
2006-02-17 |
4 |
OE |
$30.50 |
$305,000 |
D/D |
10,000 |
10,000 |
|
- |
|
Roche Robert P Jr |
Exec VP, Worldwide Pharm Ops. |
|
2006-02-15 |
4 |
GD |
$0.00 |
$0 |
D/D |
330 |
48,500 |
|
- |
|
491 Records found
|
|
Page 14 of 20 |
|
|